← back to search

Wei Yan

Nanjing University of Chinese Medicine · CN
Area of research
Genetics · Cancer Research
Research interest
Research focused on Glioma and Guideline, with related work in Oligodendroglial Tumor, IDH1, Cancer research. Notable publications include 'CGCG clinical practice guidelines for the management of adult diffuse gliomas', 'Clinical practice guidelines for the management of adult diffuse gliomas', and 'Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group'.
h-index
citations
1,993
works
13
NIH funding
primary concept
email

Recent publications

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
Frontiers in Immunology 2021cited by 10position: middledoi
Clinical practice guidelines for the management of adult diffuse gliomas
Cancer Letters 2020cited by 467position: middledoi
MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
Cancer Cell International 2020cited by 37position: middledoi
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis
Oncology Letters 2018cited by 10position: middledoi
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Cancer Letters 2016cited by 649position: middledoi
Classification based on mutations of<i>TERT</i>promoter and<i>IDH</i>characterizes subtypes in grade II/III gliomas
Neuro-Oncology 2016cited by 122position: middledoi
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
Oncotarget 2015cited by 162position: middledoi
Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma
Scientific Reports 2015cited by 79position: middledoi
Prognostic Value of a Nine‐Gene Signature in Glioma Patients Based on <scp>mRNA</scp> Expression Profiling
CNS Neuroscience & Therapeutics 2013cited by 127position: middledoi
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China
Journal of Cancer Research and Clinical Oncology 2013cited by 63position: middledoi
Whole‐Genome <scp>mRNA</scp> Expression Profiling Identifies Functional and Prognostic Signatures in Patients with Mesenchymal Glioblastoma Multiforme
CNS Neuroscience & Therapeutics 2013cited by 27position: middledoi
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group
Neuro-Oncology 2012cited by 170position: firstdoi
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome
Neuro-Oncology 2012cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tao Jiang · Xinjiang Medical University7 papers (2012–2021)Yongping You · Jiangsu Provincial Hospital of Traditional Chinese Medicine6 papers (2012–2020)Wei Zhang · South China Agricultural University6 papers (2012–2021)Yanwei Liu · Capital Medical University4 papers (2012–2013)Zhaoshi Bao · Harbin Medical University3 papers (2012–2013)Shouwei Li · Southwest University3 papers (2012–2016)Mingyang Li · Chinese PLA General Hospital3 papers (2013–2013)Kun Yao · Central South University2 papers (2015–2016)Yongzhi Wang · Capital University2 papers (2012–2015)Yinyan Wang · The University of Sydney2 papers (2015–2016)Chuanlu Jiang · Fudan University2 papers (2012–2015)Xiaoxia Peng · Beijing Children’s Hospital2 papers (2015–2016) · 2 papers (2013–2013)Chunsheng Kang · Tianjin Medical University General Hospital2 papers (2012–2012)Xiaoguang Qiu · Beijing Tian Tan Hospital2 papers (2015–2016)Pei Yang · Harbin Medical University2 papers (2015–2016)Baoshi Chen · Capital Medical University2 papers (2015–2016)Chenxing Wu · Xidian University2 papers (2015–2016)Hongjun Wang · Stevens Institute of Technology2 papers (2013–2015)Ling Chen · Nantong University2 papers (2013–2013)